WPRIM Management System> DCMS> Journal of Experimental Hematology> 2016> 24> 5

Volume: 24 Issue: 5

1. Expression and Clinical Significance of N-cadherin in Bone Marrow Leukemic Cells Derived from Patients with Acute Leukemia. Page:1312—1318
2. LNK Gene Single Nucleotide Polymorphisms and Acute Leukemia Susceptibility. Page:1305—1311
3. Application of Bisulfite Sequencing PCR in Detecting the Abnormal Methylation of Suppressor Gene of Wnt Signaling Pathway in Acute Promyelocytic Leukemia. Page:1299—1304
4. Changes of ADAMTS13 Activity and TSP1 Level in Patients with Hematologic Malignancies. Page:1294—1298
5. Value of a Panel Fluorescence in Situ Hybridization in Three Kinds of Hematological Malignancies. Page:1289—1293
6. Indentification and Sequence Analysis of A Individual with B305 Blood Group Gene Subtypes of ABO Variant. Page:1563—1566
7. Identification of A Novel HLA-B*13:92 Allele and Analysis of Its 3D Model Structure. Page:1558—1562
8. Research Progress on Roles of Platelets in Tissue Repair -Review. Page:1603—1606
9. Pulsed High-dose Dexamethasone Therapy and Its Application in Children with Immune Thrombocytopenia-Review. Page:1598—1602
10. Significance and Clinical Application of the Establishment of RhD/C/c/E/e Blood Group Base in Chinese Nanyang City. Page:1583—1587
11. Effect of RBC Transfusion on T Lymphocyte Subsets of Patients with Hematologic Malignancies. Page:1577—1582
12. Prevalence of Parvovirus B19 Infection in Chinese Xiamen Area Blood Donors. Page:1572—1576
13. Expression and Subcellular Distribution of Costimulatory Molecules B7-H1,B7-H3 and B7-H4 in Human Hematologic Malignancy Cell Lines. Page:1539—1546
14. Effect of Different Procedures from Blood Cell Separators on Autologous PBSC Collection Efficiency. Page:1529—1532
15. Relationship of Serum D-dimer, Fibrinogen, C Reactive Protein and Interleukin 6 with Thrombus Dissolution Volume in Acute Iliac Femoral Vein Thrombosis Model Rats. Page:1523—1528
16. Analysis of HPA gene Polymorphisms in Children with Acute or Chronic ITP. Page:1518—1522
17. Thrombocytopoietic Efficacy of Pegylated Recombinant Human Interleukin-11 Mutein in Myelosuppressed Mice. Page:1511—1517
18. Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome. Page:1505—1510
19. Correlation of SNP of IL-2-330T/G Gene with Genetic Susceptibility and Efficacy of Immunosuppressive Therapy in Patients with Aplastic Anemia. Page:1500—1504
20. Clinical Characteristics of 223 Chinese Patients with Hemophilia in A Medical Center of Gansu Province in China. Page:1495—1499
21. Platelets Decrease the Sensitivity of Leukemia Cell L1210 to Multiple Drugs via Activiting The AKT and ERK Signalling Pathway. Page:1489—1494
22. Clinical Comparation of Two Kinds of Chemotherapy Regimen in the Treatment of Elderly MDS Patients with AML Transformed by Abnormal Proliferation of Bone Marrow. Page:1484—1488
23. Expression of miR-550a-5p in Myelodysplastic Syndrome and Its Prediction of Target Genes. Page:1476—1483
24. Effect of CP Metronomic Chemotherapy on RPMI 8226 Cell Proli-feration and Notch1/NF-κB Signaling Pathway In Vitro. Page:1470—1475
25. Expression Level of S100A6 mRNA in MM and Its Clinical Significance. Page:1466—1469
26. Synergistic Inhibitory Effect of Arsenic Trioxide Combined with Itraconazole on Hedgehog Pathway of Multiple Myeloma NCI-H929 Cells. Page:1459—1465
27. Effect of BD Regimen Combined with Cyclophosphamide and Pirarubicin in Treatment of Relapse/Refractory Multiple Myeloma. Page:1454—1458
28. Effects of VPA on the Expression of Notch Signaling Pathway in Multiple Myeloma RPMI 8226 Cell Line. Page:1449—1453
29. Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia. Page:1437—1442
30. Correlation between Expression of CD200 and Regulatory T Cells in Multiple Myeloma and Its Significance in Prognostic Stratification. Page:1427—1432
31. Effect of GRK6 on Proliferation of Multiple Myeloma MM1R Cells and Its Mechanism. Page:1421—1426
32. Manifestations of PET/CT Imaging in Primary Central Nervous System Lymphoma. Page:1416—1420
33. Infection Status and Prognosis Analysis of Epstein-Barr Virus in Patients with Newly Diagnosed Hodgkin's Lymphoma. Page:1410—1415
34. Effect of Lymphocyte/Monocyte Ratio on Clinical Features and Prognosis of Patients with Primary Gastrointestinal Diffuse Large B Cell Lymphoma. Page:1404—1409
35. Effects of Hepatovirus B Infection on the Hematopoietic Stem Cell Collection and Implantment in Lymphoma Patients Received Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation. Page:1397—1403
36. Quantitation of Circulating Cell-free DNA in Patients with Lymphoma and Its Clinical Significance. Page:1390—1396
37. Change of TK1 Expression Level in NHL Patients before and after Chemotherapy and Its Clinical Significance. Page:1386—1389
38. Expression and Prognostic Significance of H3K27 Trimethylation Protein in DLBCL. Page:1379—1385
39. Diagnostic Value of CD64Index of Neutrophils for Patients with Leukemia Combined with Early Infection. Page:1375—1378
40. Reversal Effect of Dihydromyricetin on Drug Resistance of K562/A02 Cell Line to Adriamycin. Page:1369—1374
41. Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Evaluating Diffuse Tumor Infiltration of Bone Marrow in Patients with Acute Leukemia. Page:1365—1368
42. Effect of Anti-CD44 Monoclonal Antibody A3D8 on Expression of AP-1 in HL-60 Cells. Page:1360—1364
43. Clinicopathologic Characteristics and Outcome of Isolated Ovarian Relapse in Adolescent with Acute Lymphoblastic Leukemia. Page:1354—1359
44. Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases. Page:1348—1353
45. Effect of Decitabine in Combination with Arsenic Trioxide on Prolife-ration and Apoptosis of Human Acute Myeloid Leukemia MV4-11 Cells. Page:1343—1347
46. Effects of Scutellaria Barbata on VEGF Expression in K562 Cells. Page:1339—1342
47. Clinical Efficacy of Decitabine Combined with Modified CAG Regimen for Relapse/Refractory Acute Myeloid Leukemia with AML1-ETO. Page:1334—1338
48. Establishment of Mouse Model with Humanized Chronic Myeloid Leukemia. Page:1329—1333
49. Establishment and Identification of Mouse Model of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia. Page:1324—1328
50. Expression and Significance of Insulin-like Growth Factor Binding Protein 3 in Patients with Acute Myeloid Leukemia. Page:1319—1323
51. Research Progress on Role of Flow Cytometry in Diagnosis of Multiple Myeloma -Review. Page:1611—1614
52. Research Progress in Detection of Malignant Hematologic Diseases by Bio-electrochemistry -Review. Page:1607—1610
53. Immune Tolerance Mediated by TIM-3,LAG-3 and BTLA and Their Reversion in Hematological Malignancies-Review. Page:1594—1597
54. Research Progress of Necroptosis in Hematological Malignancies -Review. Page:1588—1593
55. Application of Multiplex PCR for the Screening Di(b-),Co(a-) Rare Blood Group in Chinese Xinjiang Minorities. Page:1567—1571
56. Knock-down of Pre-mRNA Splicing Factor Prp19 Causes Chromosome Misalignment and Prometaphase Arrest. Page:1552—1557
57. Change Trend of Viablity, Apoptosis and ROS Production of Neutrophil in vitro Culture. Page:1547—1551
58. Imbalance of Tc and Th in Peripheral Blood of Patients with Systemic Lupus Erythematosus and Its Significance. Page:1533—1538
59. Expression of Blimp-1 mRNA in Bone Marrow Mononuclear Cells in Multiple Myeloma Patients and Its Clinical Significance. Page:1443—1448
60. Relationship between Bone Markers and the Progression of Multiple Myeloma. Page:1433—1436